Fundz

Vicapsys Life Sciences, Inc. reported raising in an initial SEC Form D filing

PUBLIC · VICPJan 08, 2018

Round Type

Venture

SawaneeBiotechnology

Quick answer

Vicapsys Life Sciences raised an undisclosed amount in a funding round, dated January 8, 2018. Vicapsys Life Sciences is based in Sawanee, Georgia, United States.

How much did Vicapsys Life Sciences raise?
Vicapsys Life Sciences raised an undisclosed amount in a funding round on January 8, 2018.
What does Vicapsys Life Sciences do?
Legal Name of Vicapsys is Vicapsys Life Sciences, Inc. Vicapsys focused on leveraging natural pathways in a manner to achieve beneficial therapies without causing systemic harm.
Where is Vicapsys Life Sciences based and how big is it?
Vicapsys Life Sciences is based in Sawanee, Georgia, United States.
Who are the decision-makers at Vicapsys Life Sciences?
Fundz holds 1 contact at Vicapsys Life Sciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vicapsys Life Sciences that raised within 45 days of this round, from Fundz verified event records.

Who to call at Vicapsys Life Sciences, and when

A new round usually means Vicapsys Life Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vicapsys Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vicapsys Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vicapsys Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vicapsys Life Sciences

Location

7778 MCGINNIS FERRY RD. #270

Sawanee, Georgia, United States

About

Legal Name of Vicapsys is Vicapsys Life Sciences, Inc. Vicapsys focused on leveraging natural pathways in a manner to achieve beneficial therapies without causing systemic harm. CXCL12, a pleiotropic cytokine that can be optimally formulated to achieve therapeutic outcomes in various indications, is at the heart of the technology. They are currently focused on curing Type 1 diabetes by ensuring thelong-term survival of transplanted islet cells with a formulation that inhibits the development of the foreign body response and immune protection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vicapsys Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Vicapsys Life Sciences. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vicapsys Life Sciences's next move

See what Strategic adds

Vicapsys Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.